Gildan Q2 2026 net sales surge 72% to $1.58B, adjusted margin hits 22.3%, and divests HanesBrands Australia

What happened

Gildan reported second-quarter 2026 net sales of $1.58 billion, a 72.3% year-over-year jump that includes contributions from the HanesBrands acquisition closed in late 2025. Adjusted operating margin expanded sharply to 22.3%, reflecting early synergy realization and cost discipline. Concurrently, the company announced the sale of HanesBrands Australia, streamlining the portfolio toward higher-return segments. Combined with the integration progress, these results affirm Gildan’s cost-leadership model and strengthening FCF capability. While leverage remains a near-term watchpoint, the earnings beat and divestiture de-risks the investment case and supports the path to sub-2x net debt/EBITDA.

Implication

The Q2 beat and margin expansion confirm synergy delivery is ahead of plan, with adjusted operating margin already exceeding pre-acquisition levels. The sale of HanesBrands Australia shows management’s disciplined approach to capital allocation, trimming non-core assets and likely improving returns on capital. With Activewear momentum intact and integration risks diminishing, the investment thesis strengthens—Gildan’s cost-leadership and scale advantages are more defensible. Investors should monitor de-leveraging pace and potential tariff headwinds, but the raised bar on execution supports a continued overweight stance.

Thesis delta

Gildan’s Q2 2026 results materially de-risk the HanesBrands integration, with synergies appearing earlier than modeled and adjusted margins reaching 22.3%. The divestiture of HanesBrands Australia further refines the value proposition, suggesting management is focused on return-accretive actions. This shifts the thesis from 'integration watch' to 'synergy execution and capital-return generation,' warranting higher conviction in the BUY case.